Nasdaq

Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema

Approval of First Minimally Invasive Treatment Option in Japan that Helps Patients with Advanced Disease Breathe Easier and Have a Better Quality of Life Over 600,000 Japanese patients suffer from ...
Medical Xpress

Endobronchial valve treatment appears to improve lung function in patients with severe emphysema

People with severe emphysema may breathe better after a minimally invasive procedure that places valves in the airways leading to diseased portions of their lungs, according to a randomized, ...
Business Wire

The New 2020 Report from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Gives Highest Evidence Rating to Endobronchial Valves, including the Zephyr Valve ...

With significant evidence now in place for endobronchial valve treatment, we can now offer patients a choice in treatment options.” Bronchoscopic lung volume reduction with the Zephyr Valve is a ...
Nasdaq

Zephyr® Valve Treatment Provides Long-Term Quality of Life and Lung Function Improvements for Patients with Severe COPD/Emphysema

New Data Presented at ATS 2021 International Conference Shows Positive, Sustained Benefits to Patients Treated with this First Minimally Invasive, Non-drug Treatment Option REDWOOD CITY, Calif., May ...
Medscape

Endobronchial Valve Has IMPACT on Homogeneous Emphysema

LONDON, United Kingdom — An endobronchial valve placed in the lung of a patient with homogeneous emphysema can lead to clinically meaningful improvements in lung function, exercise tolerance, and ...
Medscape

FDA Clears Zephyr Endobronchial Valve to Treat Severe Emphysema

The US Food and Drug Administration (FDA) has approved the Zephyr Endobronchial Valve (Pulmonx Corp) to treat breathing difficulty associated with severe emphysema. "Treatment options are limited for ...
clinicaladvisor.com

Endobronchial Valve Therapy: A Nonsurgical Option for Advanced Emphysema

Pulmonary emphysema Bronchoscopic lung volume reduction with valve replacement shows the most promise for improving lung function, exercise tolerance, and quality of life in patients with advanced ...
The American Journal of Managed Care

COPD Symptoms Improved in Case Study of Endobronchial Valve Treatment

Symptoms of dyspnea in a patient with chronic obstructive pulmonary disease (COPD), which were caused by pulmonary hyperinflation, were improved by endobronchial valve treatment. Endobronchial valve ...
Business Insider

Expanded Insurance Coverage Makes Endobronchial Valve Treatment for Severe Emphysema Available to More Patients

CENTER VALLEY, Pa., June 23, 2020 /PRNewswire/ -- Olympus recently announced an expansion of insurance coverage for the Spiration® Valve System, which has been demonstrated to improve quality of life ...
News Medical

Pulmonx announces FDA approval of Zephyr Endobronchial Valve to treat severe emphysema

Pulmonx ® Corp. announced today that the U.S. Food and Drug Administration (FDA) has approved the Zephyr ® Endobronchial Valve System for treating severe emphysema patients. The Zephyr Valve is the ...
Business Wire

The New 2020 Report from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Gives Highest Evidence Rating to Endobronchial Valves, including the Zephyr Valve ...

Endobronchial valve treatment for emphysema is supported by a rich body of high-quality evidence, and is now a compelling alternative to lung volume reduction surgery (also evidence level A); ...